Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.

[1]  G. Niccoli,et al.  The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries. , 2021, Progress in cardiovascular diseases.

[2]  M. Biffi,et al.  Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy , 2021, Heart.

[3]  Matthew W. Martinez,et al.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.

[4]  F. Crea,et al.  Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy. , 2019, Circulation. Cardiovascular imaging.

[5]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[6]  Z. Siudak,et al.  Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry , 2018, Journal of Thrombosis and Thrombolysis.

[7]  B. Lindahl,et al.  Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease. , 2018, International journal of cardiology.

[8]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[9]  M. Rudnicki,et al.  Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document , 2015, Orphanet Journal of Rare Diseases.

[10]  M. Russo,et al.  Microvascular angina as prehypertrophic presentation of Fabry disease cardiomyopathy. , 2014, Circulation.

[11]  M. Yacoub,et al.  Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson–Fabry disease , 2013, European journal of heart failure.

[12]  O. Rimoldi,et al.  The coronary circulation and blood flow in left ventricular hypertrophy. , 2012, Journal of molecular and cellular cardiology.

[13]  M. Russo,et al.  Angina in Fabry Disease Reflects Coronary Small Vessel Disease , 2008, Circulation. Heart failure.

[14]  P. Camici.  Coronary microvascular dysfunction in patients with cardiomyopathies. , 2008, Circulation. Heart failure.

[15]  I. Olivotto,et al.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[16]  E. Uyama,et al.  High incidence of thrombosis in Fabry's disease. , 1997, Internal medicine.